vs

Side-by-side financial comparison of Spectral AI, Inc. (MDAI) and TECHPRECISION CORP (TPCS). Click either name above to swap in a different company.

TECHPRECISION CORP is the larger business by last-quarter revenue ($7.1M vs $4.1M, roughly 1.7× Spectral AI, Inc.). Spectral AI, Inc. runs the higher net margin — 25.7% vs -20.8%, a 46.5% gap on every dollar of revenue. On growth, TECHPRECISION CORP posted the faster year-over-year revenue change (-6.9% vs -46.3%). Over the past eight quarters, TECHPRECISION CORP's revenue compounded faster (-9.2% CAGR vs -19.6%).

Spectral AI, Inc. is a medical technology firm specializing in AI-powered diagnostic imaging solutions primarily for burn and wound care. It develops non-invasive imaging tools that enable healthcare providers to deliver faster, more accurate treatment assessments, serving clinical and healthcare partner networks across North America and European markets.

TechPrecision Corp is a manufacturer of custom high-precision metal fabricated components and integrated systems, serving aerospace, defense, medical technology, renewable energy, and industrial end markets primarily across North America and Europe. It specializes in producing tight-tolerance, mission-critical parts that adhere to rigorous industry quality requirements.

MDAI vs TPCS — Head-to-Head

Bigger by revenue
TPCS
TPCS
1.7× larger
TPCS
$7.1M
$4.1M
MDAI
Growing faster (revenue YoY)
TPCS
TPCS
+39.3% gap
TPCS
-6.9%
-46.3%
MDAI
Higher net margin
MDAI
MDAI
46.5% more per $
MDAI
25.7%
-20.8%
TPCS
Faster 2-yr revenue CAGR
TPCS
TPCS
Annualised
TPCS
-9.2%
-19.6%
MDAI

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
MDAI
MDAI
TPCS
TPCS
Revenue
$4.1M
$7.1M
Net Profit
$1.1M
$-1.5M
Gross Margin
45.2%
5.4%
Operating Margin
-54.9%
-19.1%
Net Margin
25.7%
-20.8%
Revenue YoY
-46.3%
-6.9%
Net Profit YoY
113.9%
-84.4%
EPS (diluted)
$0.04
$-0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MDAI
MDAI
TPCS
TPCS
Q4 25
$4.1M
$7.1M
Q3 25
$3.8M
$9.1M
Q2 25
$5.1M
$7.4M
Q1 25
$6.7M
$9.5M
Q4 24
$7.6M
$7.6M
Q3 24
$8.2M
$8.9M
Q2 24
$7.5M
$8.0M
Q1 24
$6.3M
$8.6M
Net Profit
MDAI
MDAI
TPCS
TPCS
Q4 25
$1.1M
$-1.5M
Q3 25
$-3.6M
$825.0K
Q2 25
$-8.0M
$-597.0K
Q1 25
$2.9M
$112.0K
Q4 24
$-7.6M
$-799.0K
Q3 24
$-1.5M
$-601.0K
Q2 24
$-2.9M
$-1.5M
Q1 24
$-3.2M
$-5.1M
Gross Margin
MDAI
MDAI
TPCS
TPCS
Q4 25
45.2%
5.4%
Q3 25
42.7%
27.1%
Q2 25
45.2%
14.0%
Q1 25
47.2%
22.0%
Q4 24
44.0%
13.0%
Q3 24
44.9%
11.3%
Q2 24
44.3%
3.0%
Q1 24
46.6%
14.3%
Operating Margin
MDAI
MDAI
TPCS
TPCS
Q4 25
-54.9%
-19.1%
Q3 25
-88.1%
10.4%
Q2 25
-41.9%
-6.3%
Q1 25
-13.4%
3.9%
Q4 24
-14.6%
-9.1%
Q3 24
-10.8%
-5.5%
Q2 24
-32.7%
-16.8%
Q1 24
-33.9%
-28.6%
Net Margin
MDAI
MDAI
TPCS
TPCS
Q4 25
25.7%
-20.8%
Q3 25
-93.7%
9.1%
Q2 25
-157.3%
-8.1%
Q1 25
43.2%
1.2%
Q4 24
-99.8%
-10.5%
Q3 24
-18.4%
-6.7%
Q2 24
-38.3%
-18.3%
Q1 24
-50.7%
-59.5%
EPS (diluted)
MDAI
MDAI
TPCS
TPCS
Q4 25
$0.04
$-0.15
Q3 25
$-0.13
$0.08
Q2 25
$-0.31
$-0.06
Q1 25
$0.11
$0.01
Q4 24
$-0.42
$-0.08
Q3 24
$-0.08
$-0.06
Q2 24
$-0.16
$-0.16
Q1 24
$-0.19
$-0.59

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MDAI
MDAI
TPCS
TPCS
Cash + ST InvestmentsLiquidity on hand
$15.4M
$50.0K
Total DebtLower is stronger
$9.3M
Stockholders' EquityBook value
$-5.7M
$8.0M
Total Assets
$21.4M
$32.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MDAI
MDAI
TPCS
TPCS
Q4 25
$15.4M
$50.0K
Q3 25
$10.5M
$220.0K
Q2 25
$10.5M
$143.0K
Q1 25
$14.1M
$195.0K
Q4 24
$5.2M
$165.0K
Q3 24
$3.7M
$132.0K
Q2 24
$6.9M
$44.8K
Q1 24
$10.2M
$138.0K
Total Debt
MDAI
MDAI
TPCS
TPCS
Q4 25
$9.3M
Q3 25
Q2 25
Q1 25
$7.8M
$3.0K
Q4 24
$2.8M
$19.0K
Q3 24
$1.0M
Q2 24
Q1 24
Stockholders' Equity
MDAI
MDAI
TPCS
TPCS
Q4 25
$-5.7M
$8.0M
Q3 25
$-8.2M
$9.1M
Q2 25
$-9.2M
$8.2M
Q1 25
$-1.6M
$8.7M
Q4 24
$-7.3M
$8.1M
Q3 24
$-4.8M
$8.9M
Q2 24
$-4.7M
$7.9M
Q1 24
$-2.5M
$7.8M
Total Assets
MDAI
MDAI
TPCS
TPCS
Q4 25
$21.4M
$32.8M
Q3 25
$15.3M
$33.8M
Q2 25
$16.0M
$32.1M
Q1 25
$20.7M
$33.5M
Q4 24
$12.1M
$32.2M
Q3 24
$11.6M
$35.0M
Q2 24
$13.9M
$35.7M
Q1 24
$15.5M
$34.7M
Debt / Equity
MDAI
MDAI
TPCS
TPCS
Q4 25
Q3 25
Q2 25
Q1 25
0.00×
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MDAI
MDAI
TPCS
TPCS
Operating Cash FlowLast quarter
$-2.6M
$183.0K
Free Cash FlowOCF − Capex
$-827.0K
FCF MarginFCF / Revenue
-11.7%
Capex IntensityCapex / Revenue
14.2%
Cash ConversionOCF / Net Profit
-2.43×
TTM Free Cash FlowTrailing 4 quarters
$-4.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MDAI
MDAI
TPCS
TPCS
Q4 25
$-2.6M
$183.0K
Q3 25
$-2.5M
$-1.1M
Q2 25
$-3.4M
$646.0K
Q1 25
$-1.5M
$396.0K
Q4 24
$469.0K
$-570.0K
Q3 24
$-1.6M
$-532.0K
Q2 24
$-5.4M
$107.0K
Q1 24
$-2.7M
$-452.0K
Free Cash Flow
MDAI
MDAI
TPCS
TPCS
Q4 25
$-827.0K
Q3 25
$-2.1M
Q2 25
$-604.0K
Q1 25
$-930.0K
Q4 24
$-1.7M
Q3 24
$-2.0M
Q2 24
$-94.0K
Q1 24
$-900.0K
FCF Margin
MDAI
MDAI
TPCS
TPCS
Q4 25
-11.7%
Q3 25
-22.9%
Q2 25
-8.2%
Q1 25
-9.8%
Q4 24
-22.9%
Q3 24
-21.8%
Q2 24
-1.2%
Q1 24
-10.5%
Capex Intensity
MDAI
MDAI
TPCS
TPCS
Q4 25
14.2%
Q3 25
11.0%
Q2 25
16.9%
Q1 25
14.0%
Q4 24
15.4%
Q3 24
15.9%
Q2 24
2.5%
Q1 24
5.2%
Cash Conversion
MDAI
MDAI
TPCS
TPCS
Q4 25
-2.43×
Q3 25
-1.31×
Q2 25
Q1 25
-0.52×
3.54×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MDAI
MDAI

Segment breakdown not available.

TPCS
TPCS

Defense$6.7M94%
Other$410.0K6%

Related Comparisons